Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloset as an adjunct to insulin and metformin in type 2 diabetes
NCT01474018Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2011
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bromocriptine in type 2 diabetes mellitus (T2DM), sponsored by UT Southwestern Medical Center. Started Nov 2011; status: completed.
02
Drugs
bromocriptine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01474018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01474018.